- Terms of use
- Privacy Notice
- Accessibility
- Cookie Policy
- ©2024 Freeline
Paul Schneider
Chief Financial Officer
Paul has more than 20 years of global financial, commercial and operational experience in the life sciences industry. Prior to joining Freeline in May 2022, he was Senior Vice President, Finance and Operations at Exo Therapeutics; Senior Vice President, Finance at Casebia Therapeutics, and has also held senior corporate finance positions at Aegerion Pharmaceuticals, Systagenix Wound Management, Shire Human Genetics Therapies and Transkaryotic Therapies. Paul began his professional career at Coopers and Lybrand. He holds a Bachelor of Science in Accounting from Boston College and a Certified Public Accountant license in Massachusetts.
Connect with Paul:
We are looking for talented people to join the team